Considering symptom burden and social relationships during sexual health management in ovarian suppression-treated women with breast cancer.
단면연구
2/5 보강
OpenAlex 토픽 ·
Cancer survivorship and care
Reproductive Biology and Fertility
Menopause: Health Impacts and Treatments
[BACKGROUND] Ovarian function suppression (OFS) treatment induces sudden menopause in women with breast cancer, leading to severe sexual issues.
- 표본수 (n) 339
- 95% CI 1.33-29.97
- 연구 설계 cross-sectional
APA
Yuan Li, Yunyun Chen, et al. (2026). Considering symptom burden and social relationships during sexual health management in ovarian suppression-treated women with breast cancer.. Communications medicine. https://doi.org/10.1038/s43856-026-01559-w
MLA
Yuan Li, et al.. "Considering symptom burden and social relationships during sexual health management in ovarian suppression-treated women with breast cancer.." Communications medicine, 2026.
PMID
41991695 ↗
Abstract 한글 요약
[BACKGROUND] Ovarian function suppression (OFS) treatment induces sudden menopause in women with breast cancer, leading to severe sexual issues. While overall sexual health research is limited, evidence specific to OFS-treated women is even scarcer. We aim to compare the symptom burden and interpersonal relationships of sexually active (SAW) and inactive women (SIW).
[METHODS] A cross-sectional study was conducted from October 2023 to July 2024. Participants completed questionnaires including demographic/clinical data and scales assessing symptom burden, social support, and social alienation. Convenience sampling included 1134 OFS women (SIW, n = 339; SAW, n = 795).
[RESULTS] Before and after overlap weighting (OW), SIW is consistently associated with higher overall symptom burden; post-OW, it correlates only with phase-specific poorer social attributes. Initially, a lower 'lost interest in sex' burden correlates with SIW, but this relationship reverses after adjustment. Following OW, anxiety (OR 6.32, 95%CI 1.33-29.97), mood swings (OR 3.84, 95% CI 1.05-14.12), and depression (OR 2.39, 95%CI 1.00-5.69) show the highest odds of occurrence in SIW vs. SAW. Relative to "Independent & Balanced", married SIW treated for 1-3 months align with "Isolated & Overburdened". Conversely, SAW profiles vary: married women treated for 3-5 years belong to "Selective Sexual Burden," married women belong to the "Latently Stressed", while those treated for 1-3 months fall into "Vaginal Symptom-Focused" or "Multi-System Diffuse Distress".
[CONCLUSIONS] Sex life is associated with OFS women's physical, mental, and interpersonal burdens. We identified SIW/SAW phenotyping categories with different symptom and interpersonal burdens and women with different social support sensitivities, providing a theoretical basis for future interventions.
[METHODS] A cross-sectional study was conducted from October 2023 to July 2024. Participants completed questionnaires including demographic/clinical data and scales assessing symptom burden, social support, and social alienation. Convenience sampling included 1134 OFS women (SIW, n = 339; SAW, n = 795).
[RESULTS] Before and after overlap weighting (OW), SIW is consistently associated with higher overall symptom burden; post-OW, it correlates only with phase-specific poorer social attributes. Initially, a lower 'lost interest in sex' burden correlates with SIW, but this relationship reverses after adjustment. Following OW, anxiety (OR 6.32, 95%CI 1.33-29.97), mood swings (OR 3.84, 95% CI 1.05-14.12), and depression (OR 2.39, 95%CI 1.00-5.69) show the highest odds of occurrence in SIW vs. SAW. Relative to "Independent & Balanced", married SIW treated for 1-3 months align with "Isolated & Overburdened". Conversely, SAW profiles vary: married women treated for 3-5 years belong to "Selective Sexual Burden," married women belong to the "Latently Stressed", while those treated for 1-3 months fall into "Vaginal Symptom-Focused" or "Multi-System Diffuse Distress".
[CONCLUSIONS] Sex life is associated with OFS women's physical, mental, and interpersonal burdens. We identified SIW/SAW phenotyping categories with different symptom and interpersonal burdens and women with different social support sensitivities, providing a theoretical basis for future interventions.
같은 제1저자의 인용 많은 논문 (5)
- The efficacy of botulinum toxin type A treatment and surgery for acute acquired comitant esotropia.
- Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China.
- Hyaluronic Acid Compound Filling Plus Mesotherapy vs Botulinum Toxin A for the Treatment of Horizontal Neck Lines: A Multicenter, Randomized, Evaluator-Blinded, Prospective Study in Chinese Subjects.
- Correction to: Hyaluronic Acid Compound Filling Plus Mesotherapy vs Botulinum Toxin A for the Treatment of Horizontal Neck Lines: A Multicenter, Randomized, Evaluator-Blinded, Prospective Study in Chinese Subjects.
- The use of botulinum toxin A in upper lip augmentation.